NEO — NEOGENOMICS INC
—
Nasdaq ·
Unknown ·
Unknown ·
CIK 1077183 ·
Last close
$9.27
Market Cap
$1.21B
52W High
$10.33
52W Low
$7.07
ADV30
2,229,911
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 186,672,000 | 80,864,000 | -18,241,000 | -17,106,000 | 1,346,531,000 | 146,143,000 | 517,771,000 |
| Dec 2025 | 190,170,000 | 83,343,000 | -12,788,000 | -9,881,000 | 1,359,830,000 | 159,618,000 | 523,268,000 |
| Sep 2025 | 187,797,000 | 80,446,000 | -19,928,000 | -27,129,000 | 1,374,780,000 | 164,117,000 | 536,490,000 |
| Jun 2025 | 181,330,000 | 77,258,000 | -27,587,000 | -45,092,000 | 1,393,950,000 | 154,723,000 | 539,910,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$22,420,000
Investing CF
$-20,896,000
Financing CF
$-201,575,000
CapEx
$-27,508,000
Dividends Paid
—
Buybacks
$-338,000
EPS Diluted TTM
$-0.77
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-450,912,000
Inventory
$29,837,000
Receivables
$167,424,000
ST Investments
$0
EBIT TTM
$-99,456,000
Pretax Income TTM
$-102,189,000
Interest Exp TTM
$2,733,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$745,969,024
EBITDA
$4,267,000
Free Cash Flow
$33,170,624
Enterprise Value
$1,464,240,768
Total Cash
$146,143,008
Total Debt
$408,528,992
Shares Out
130,211,780
Trailing EPS
$-0.77
Book Value
$6.49
ROE
-11.6%
ROA
-2.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 727,332,000 | -88,128,000 | -108,025,000 | 1,359,830,000 | 523,268,000 | — | 5,230,000 |
| Dec 2024 | 660,566,000 | -85,448,000 | -78,726,000 | 1,638,038,000 | 735,699,000 | — | 7,023,000 |
| Dec 2023 | 591,643,000 | -96,648,000 | -87,968,000 | 1,681,229,000 | 739,692,000 | — | -1,953,000 |
| Dec 2022 | 509,728,000 | -153,107,000 | -144,250,000 | 1,740,034,000 | 742,011,000 | — | -65,993,000 |
TTM Snapshot
Revenues TTM
$569,900,000
NetIncome TTM
$-102,777,000
OpCashFlow TTM
$0
Assets (Latest)
$1,638,038,000
Forward EPS
$0.36
News headlines (Yahoo Finance, 1h cache)
NeoGenomics to Present New Research at ASCO Annual Meeting 2026
2026-05-26 11:05 · Yahoo
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know
2026-05-17 09:24 · Yahoo
NeoGenomics to Participate in Upcoming Investor Conferences
2026-05-15 13:05 · Yahoo
3 Russell 2000 Stocks We’re Skeptical Of
2026-05-12 14:04 · Yahoo
A Look At NeoGenomics (NEO) Valuation After Q1 2026 Results And Epic Aura Oncology Integration
2026-05-01 07:33 · Yahoo
NeoGenomics Shares Jump on Earnings and Analyst Upgrades
2026-04-29 11:27 · Yahoo
NeoGenomics Inc (NEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
2026-04-29 07:09 · Yahoo
NeoGenomics Q1 Earnings Call Highlights
2026-04-28 22:47 · Yahoo
NeoGenomics (NEO) Q1 2026 Earnings Transcript
2026-04-28 22:12 · Yahoo
NeoGenomics (NEO) Q1 2025 Earnings Transcript
2026-04-28 20:22 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.